Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. It has a collaboration agreement with Journey Biosciences, Inc. Cardinal Health, Inc. was founded in 1979 and is headquartered in Dublin, Ohio.
Bear of the Day: Cardinal Health (CAH) Sometimes, it is easy to get caught up in the momentum of a fast-moving stock. We have all heard the old adage of “Buy low and sell high” but it is equally as fun to “Buy high and sell higher.” You have to be sure that your stock that is on the move has staying power and is not just on a quick sugar high. One way to figure this out is by looking at earnings. Stocks with the strongest earnings trends tend to outperform those with weak earnings profiles. When analysts on Wall Street start moving their numbers in the wrong direction, it can lead to problems for a stock’s price. Today’s Bear of the Day is a stock that has seen earnings estimate revisions coming down. That stock is Cardinal Health CAH. Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. Currently, Cardinal Heath is a Zacks Rank #5 (Strong Sell). The reason for the unfavorable Zacks Rank is the recent earnings estimate revisions from analysts all over Wall Street. Over the last sixty days, two analysts have cut their expectations for both the current year and next year. The bearish sentiment has dropped our Zacks Consensus Estimates for the current year from $5.85 to $5.60 while next year’s number is off from $6.57 to $6.14. That current year number represents a mere 54 bps of growth over last year while next year is forecast to come in at 9.6% growth. Sales growth has still been relatively strong with 9.15% this year and 4.81% next year. https://uk.finance.yahoo.com/news/bear-day-cardinal-health-cah-120012122.html Cardinal Health, Inc. (CAH) NYSE - NYSE Delayed price. Currency in USD In watchlist 53.09+0.85 (+1.63%) At close: 14 January 04:00PM EST 53.26 +0.17 (+0.32%) After hours: 07:21PM EST
Cardinal Health to pay $13 million to resolve U.S. kickback case Mon, 31 January 2022 By Nate Raymond BOSTON (Reuters) -Drug distributor Cardinal Health Inc has agreed to pay more than $13 million to resolve allegations it gave doctors kickbacks to buy pharmaceutical products paid for by federal healthcare programs, the U.S. Justice Department said on Monday. U.S. Attorney Rachael Rollins in Boston said the Ohio-based drug distributor violated the False Claims Act by paying kickbacks to physician practices in the form of "upfront discounts." Cardinal Health acknowledged certain facts as part of the $13.125 million settlement, Rollins' office said, though the company in a statement noted that it did not admit liability as part of the deal. It said it no longer offers the term-based up-front discounts at issue in the settlement. The Justice Department said that Cardinal Health since 2013 had made payments to physician practices in advance of them buying any drugs that failed to comply with government restrictions on upfront discount arrangements. Under the Anti-Kickback Statute, drug distributors are prohibited from offering or paying any compensation to convince doctors to purchase medications for use on patients covered by the government's Medicare health insurance program. The Office of Inspector General for the U.S. Department of Health and Human Services has said distributors may legally offer commercially available discounts to customers under certain circumstances. But the department said Cardinal's payments did not meet those requirements because they were not attributable to identifiable sales of pharmaceutical products or purported rebates that the customers had not actually earned. ttps://uk.finance.yahoo.com/news/cardinal-health-pay-13-million-154741871.html
Cardinal Health (CAH) Beats Q2 Earnings and Revenue Estimates Cardinal Health (CAH) came out with quarterly earnings of $1.27 per share, beating the Zacks Consensus Estimate of $1.23 per share. This compares to earnings of $1.74 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 3.25%. A quarter ago, it was expected that this prescription drug distributor would post earnings of $1.32 per share when it actually produced earnings of $1.29, delivering a surprise of -2.27%. Over the last four quarters, the company has surpassed consensus EPS estimates just once. Cardinal , which belongs to the Zacks Medical - Dental Supplies industry, posted revenues of $45.46 billion for the quarter ended December 2021, surpassing the Zacks Consensus Estimate by 1.02%. This compares to year-ago revenues of $41.54 billion. The company has topped consensus revenue estimates three times over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Cardinal shares have added about 0.2% since the beginning of the year versus the S&P 500's decline of -3.7%. https://uk.finance.yahoo.com/news/cardinal-health-cah-beats-q2-131501223.html
